# VIA Disc Nucleus Pulposus Older Patients Pilot

> **NCT05412277** · NA · UNKNOWN · sponsor: **VIVEX Biologics, Inc.** · enrollment: 21 (actual)

## Conditions studied

- Degenerative Disc Disease
- Low Back Pain
- Disc Degeneration

## Interventions

- **OTHER:** VIA Disc Nucleus Pulposus Allograft

## Key facts

- **NCT ID:** NCT05412277
- **Lead sponsor:** VIVEX Biologics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-10-17
- **Primary completion:** 2024-08-30
- **Final completion:** 2024-12-31
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2024-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05412277

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05412277, "VIA Disc Nucleus Pulposus Older Patients Pilot". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05412277. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*